2025 Annual Report and Notice of AGM
HUTCHMED (China) Limited has announced that its 2025 Annual Report and Notice of Annual General Meeting will be distributed to shareholders on April 10, 2026, and will also be available on the company's website. The 2026 Annual General Meeting will be held as an electronic/hybrid meeting on May 12, 2026, at 4:00 pm Hong Kong Time. The company is an innovative, commercial-stage biopharmaceutical company focused on developing targeted therapies and immunotherapies for cancer and immunological diseases.
Select text to share a quote on X · sign in to keep highlights & notes in your HCM notes
Hong Kong, Shanghai & Florham Park, NJ - Thursday, April 9, 2026: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; HKEX: 13) today announces that its 2025 Annual Report, together with the Notice of Annual General Meeting and the Form of Proxy ("AGM Materials"), will be posted on April 10, 2026 to those shareholders who have elected to receive the AGM Materials in printed form. The documents can also be accessed from the HUTCHMED website (www.hutch-med.com).
The 2026 Annual General Meeting ("AGM") will be an electronic/hybrid meeting to be held at 1st Floor, Harbour Grand Kowloon, 20 Tak Fung Street, Hung Hom, Kowloon, Hong Kong on Tuesday, May 12, 2026 at 4:00 pm Hong Kong Time (9:00 am London Time), with electronic access through an online platform as detailed in the AGM Materials.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.